Results 51 to 60 of about 38,804 (267)

A Discharge Summary Prompt Reduces Postoperative Radiotherapy Delay in Head and Neck Cancer Patients

Head &Neck, EarlyView.
ABSTRACT Background Delays in postoperative radiotherapy (PORT) beyond 6 weeks are associated with worse outcomes in head and neck cancer (HNC). This study evaluated whether a discharge summary prompt could reduce PORT delay. Methods A retrospective review of patients from 2018 to 2023 was used as a pre‐intervention baseline.
Andreja Radevic, Niketna Vivek, Joaquin Austerlitz, Sindhura Sridhar, Whitney Jin, Robert Sinard, Sarah L. Rohde, Kyle Mannion, Alexander J. Langerman, Eben Rosenthal, Michael C. Topf   +10 more
wiley   +1 more source

Primary nasopharyngeal interdigitating dendritic cell tumor presentation and response to radiation therapy

Rare Tumors, 2010
We report the case of a primary nasopharyngeal interdigitating dendritic cell tumor (IDDCT). A 25-year old male presented with bilateral decreased hearing, double vision, and ataxia.
Paul W. Read, John B. Cousar, Michael G. Douvas, James F. Reibel, Asal N. Shoushtari, Randell L. Woodford, Neal E. Dunlap   +6 more
doaj   +1 more source

Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Glossotonsillar Sulcus Involvement Conveys an Unfavorable Oncological Outcome

Head &Neck, EarlyView.
ABSTRACT Background Transoral robotic surgery (TORS) is widely used in management of early‐stage primary oropharyngeal squamous cell carcinoma (OPSCC). Tumors involving the glossotonsillar sulcus (GTS) are hypothesized to confer worse oncological outcomes compared to those situated in the rest of the oropharynx, with a paucity of evidence to support ...
Johan S. Nilsson, John C. Hardman, James Tsimiklis, Bora Jeong, Maryam Khan, Jonathan Daniel, Giri Krishnan, Andrew Foreman, Suren Krishnan, John‐Charles Hodge   +9 more
wiley   +1 more source

Prognostic Impact of Lymphovascular Invasion on Distant Metastasis in HPV‐Negative Head and Neck Cancer

Head &Neck, EarlyView.
ABSTRACT Background Lymphovascular invasion (LVI) is a recognized poor prognostic factor in head and neck squamous cell carcinoma (HNSCC), particularly for regional recurrence and overall survival. However, its role in predicting distant metastasis, especially in HPV‐negative HNSCC, remains unclear. Objective To evaluate the association between LVI and
Mark Khoury, Alex Mlynarek, Keith Richardson, Nader Sadeghi, Michael Hier, Christina Tsien, George Shenouda, Khalil Sultanem, Nathaniel Bouganim, Khashayar Esfahani, Sabrina Wurzba, Marco Mascarella   +11 more
wiley   +1 more source

Primary bone marrow lymphoma: an uncommon extranodal presentation of aggressive non-hodgkin lymphomas.

, 2012
Item does not contain fulltextBone marrow involvement by lymphoma is considered a systemic dissemination of the disease arising elsewhere, although some tumors may arise primarily in the bone marrow microenvironment.
Matutes E., Campidelli, C., Rozman, M., Agostinelli, C., Pileri, S., Rozman M., Gelemur, M., CAMPIDELLI, CRISTINA, Perea, G., Acevedo A., Zucca E., Matutes, E., Martinez-Bernal, M., Martinez A., Peccatori, J., PILERI, STEFANO, Perea G., Gelemur M., Mehrjardi, A.Z., Zucca, E., Espinet B., Ponzoni M., Martinez Bernal M., Peccatori J., Martinez, A., Hebeda K. M., AGOSTINELLI, CLAUDIO, on behalf of the International Extranodal Lymphoma Study Group, Hebeda, K.M., Acevedo, A., Campo E., Mehrjardi A. Z., Espinet, B., Campo, E., López Guillermo A., Lopez-Guillermo, A., Ponzoni, M.   +36 more
core   +1 more source

Human biomarker navigator

iMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li, Qian Zhang, Zijie Wang, Zeping Gui, Jing Liu, Jingda Li, Maojun Jiang, Zukang Chang, Qingqing Han, Bendong Yang, Tariq Saeed, Jun Li, Jinghan Jia, Chenghu Song, Tong Shao, Tianhuan Peng, Xueying Zhang, Pingping Guo, Jun Luo, Gangao Yang, Yuan Wan, Gokhan Zengin, Quan Yuan, Lingru Li, Xiaohui Fan, Yang Luo, Lvyun Zhu, Yanfei Zheng, Wenjun Mao, Wenlong Sun   +29 more
wiley   +1 more source

Imaging of Extranodal Lymphoma With PET/CT

, 2011
Hodgkin disease (HD) and non-Hodgkin lymphoma (NHL) represent a spectrum of malignant neoplasms arising from the lymphoid system with an incidence of around 8% of all malignancies. Although they are generally known as tumors of lymph nodes, 25% to 40% of
Kocacelebi, Kenan, Ilica, Ahmet Turan, Asli Ayan, Savas, Recep, Recep Savas, Ayan, Asli, Ahmet Turan Ilica, Kenan Kocacelebi   +7 more
core   +1 more source

Tissue Clearing for Lymph Nodes: 3D Mapping of Nerves and the Immune Microenvironment

iNew Medicine, EarlyView.
ABSTRACT Lymph nodes (LNs) are central hubs of adaptive immunity and key relay sites for metastatic tumour cells. However, conventional two‐dimensional histology samples only a small fraction of each node, potentially missing micrometastases and multifocal involvement while obscuring long‐range spatial relationships among tumour deposits, immune ...
Guang‐Hong Su, Fei Wang, Ting‐Hong Wei, Rui Lu, Wen‐Jun Huang, Xiang Zhang, Ling Yin, Jun Li   +7 more
wiley   +1 more source

[18F]FDG PET/CT detection and therapeutic response assessment of primary multisystem extranodal diffuse large B-cell lymphoma without lymph node involvement: a case report

Frontiers in Oncology
IntroductionPrimary extranodal diffuse large B-cell lymphoma (PE-DLBCL) originates in extranodal organs and accounts for approximately 30%–40% of all DLBCL cases. PE-DLBCL involving multiple organs without lymph node involvement is uncommon. We present a
Taiping Liao, Huan Deng, Yongjun Long, Jun He, Lingxiao Li, Cong Xiao, Jun Li   +6 more
doaj   +1 more source

Cutaneous Rosai‐Dorfman Disease With MAP2K1 Mutation Treated With Encorafenib and Binimetinib

JEADV Clinical Practice, EarlyView.
ABSTRACT Rosai‐Dorfman disease (RDD) is a rare histiocytic disorder with unifocal to multisystemic involvement. Activating mutations in the MAPK/ERK pathway can occur in up to 50% of RDD cases. We report a case of cutaneous RDD (C‐RDD) with facial and truncal lesions harboring an activating MAP2K1 (MEK1) mutation that showed a complete response to a ...
Melike Ak, Reinhard Dummer, Egle Ramelyte   +2 more
wiley   +1 more source